Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Fuji
Julphar
Cantor Fitzgerald
Mallinckrodt
Dow
Daiichi Sankyo
US Army
Novartis
Baxter

Generated: February 21, 2018

DrugPatentWatch Database Preview

Esomeprazole sodium - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for esomeprazole sodium and what is the scope of esomeprazole sodium freedom to operate?

Esomeprazole sodium
is the generic ingredient in two branded drugs marketed by Accord Hlthcare, Aurobindo Pharma Ltd, Deva Holding As, Mylan Labs Ltd, Sun Pharma Global, and Astrazeneca Pharms, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.

There are seventy drug master file entries for esomeprazole sodium. Six suppliers are listed for this compound.
Pharmacology for esomeprazole sodium

US Patents and Regulatory Information for esomeprazole sodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Deva Holding As ESOMEPRAZOLE SODIUM esomeprazole sodium INJECTABLE;INTRAVENOUS 207181-001 Mar 6, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd ESOMEPRAZOLE SODIUM esomeprazole sodium INJECTABLE;INTRAVENOUS 204657-002 Aug 10, 2016 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd ESOMEPRAZOLE SODIUM esomeprazole sodium INJECTABLE;INTRAVENOUS 202686-002 May 17, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharma Global ESOMEPRAZOLE SODIUM esomeprazole sodium INJECTABLE;INTRAVENOUS 200882-001 Mar 18, 2013 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Aurobindo Pharma Ltd ESOMEPRAZOLE SODIUM esomeprazole sodium INJECTABLE;INTRAVENOUS 204657-001 Aug 10, 2016 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan Labs Ltd ESOMEPRAZOLE SODIUM esomeprazole sodium INJECTABLE;INTRAVENOUS 202686-001 May 17, 2017 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca Pharms NEXIUM IV esomeprazole sodium INJECTABLE;INTRAVENOUS 021689-002 Mar 31, 2005 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Astrazeneca Pharms NEXIUM IV esomeprazole sodium INJECTABLE;INTRAVENOUS 021689-001 Mar 31, 2005 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharma Global ESOMEPRAZOLE SODIUM esomeprazole sodium INJECTABLE;INTRAVENOUS 200882-002 Mar 18, 2013 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Accord Hlthcare ESOMEPRAZOLE SODIUM esomeprazole sodium INJECTABLE;INTRAVENOUS 205379-001 Sep 25, 2015 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for esomeprazole sodium

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Astrazeneca Pharms NEXIUM IV esomeprazole sodium INJECTABLE;INTRAVENOUS 021689-001 Mar 31, 2005 ➤ Sign Up ➤ Sign Up
Astrazeneca Pharms NEXIUM IV esomeprazole sodium INJECTABLE;INTRAVENOUS 021689-002 Mar 31, 2005 ➤ Sign Up ➤ Sign Up
Astrazeneca Pharms NEXIUM IV esomeprazole sodium INJECTABLE;INTRAVENOUS 021689-001 Mar 31, 2005 ➤ Sign Up ➤ Sign Up
Astrazeneca Pharms NEXIUM IV esomeprazole sodium INJECTABLE;INTRAVENOUS 021689-002 Mar 31, 2005 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
Moodys
Johnson and Johnson
McKesson
Covington
US Department of Justice
Accenture
Daiichi Sankyo

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot